CTVA Form 144 Filed for 37,280-Share Sale Valued at $2.77M

Rhea-AI Filing Summary

Corteva, Inc. (CTVA) reported a Form 144 notice for the proposed sale of 37,280 common shares through Merrill Lynch on the NYSE with an aggregate market value of $2,765,994.21. The securities listed were acquired through exercises and vesting of stock awards from Corteva between April 4, 2023 and August 29, 2025, with individual lots of 14,960; 9,337; 11,826; 1,092; and 65 shares. The filer represents they have no undisclosed material adverse information about the company and indicates the sales are compensatory in nature for these equity awards. No sales by the same person in the past three months were reported.

Positive

• Securities were acquired through compensatory awards, indicating sales stem from routine employee/executive compensation rather than third-party transfers
• No reported sales in the past three months for the same person, which limits concerns about rapid consecutive disposals

Negative

• Proposed sale size of 37,280 shares valued at $2,765,994.21 represents a notable cash realization by an insider, which some investors may view negatively

Insights

Securities Analyst

TL;DR: Insider proposes to sell 37,280 shares worth about $2.77M, consisting of exercised and vested awards, with no recent sales reported.

This Form 144 shows a routine planned sale under Rule 144 by a person holding equity from compensatory awards. The lots span multiple grant and vesting events, indicating proceeds arise from standard employee equity realizations rather than secondary transfers. The aggregate size (37,280 shares; $2.77M) is small relative to the stated outstanding share count (679.1M), suggesting limited immediate dilution or market impact. The filer’s representation of no undisclosed material information is standard and required by the form.

Corporate Governance Expert

TL;DR: Filing documents a compliance step for planned insider sale; transaction history is compensatory and includes multiple award dates.

The entry details acquisitions via exercise and vesting, all marked as compensatory payments, which is consistent with executive or employee compensation realization. The absence of sales in the prior three months reduces concerns about a rapid disposition pattern, but the filing itself is a disclosure trigger that investors and compliance teams use to monitor insider activity. No governance red flags or regulatory issues are evident from the provided information alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Rd NE Ste 1000 Atlanta GA 30326	37280	2765994.21	679100000	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Exercise of a Stock Award	Corteva, Inc.			14960	08/29/2025	Compensatory Payment
Common	08/29/2025	Exercise of a Stock Award	Corteva, Inc.			9337	08/29/2025	Compensatory Payment
Common	04/04/2023	Vesting of a Stock Award	Corteva, Inc.			11826	04/04/2023	Compensatory Payment
Common	02/28/2024	Vesting of Stock Awards	Corteva, Inc.			1092	02/28/2024	Compensatory Payment
Common	04/04/2024	Vesting of Stock Awards	Corteva, Inc.			65	04/04/2024	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Corteva (CTVA) disclose?

The notice discloses a proposed sale of 37,280 common shares via Merrill Lynch on the NYSE with aggregate market value of $2,765,994.21.

How were the Corteva shares being sold originally acquired?

All listed shares were acquired from Corteva through exercises or vesting of stock awards between April 4, 2023 and August 29, 2025.

Does the filing report any sales by the same person in the prior three months?

No; the filing states Nothing to Report for securities sold during the past three months by the person.

Which broker and exchange are named for the proposed sale?

The broker is Merrill Lynch (Atlanta address provided) and the sale is planned on the NYSE.

What representation does the filer make about material information?

By signing, the person represents they do not know any material adverse information